4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-009047
Chief Business Officer sold 40,000 shares at $14.09 ($563,600)
- Chief Business Officer acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Savill Corrine · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,000 | $4.30 | $172,000 | 205,990 | D |
| 2024-01-29 | Sale : show line 2 in the form 10b5-1 | −40,000 | $14.09 | $563,600 | 165,990 | D |
| Open-market sales · 40,000 sh · avg $14.09 · $563,600 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-29 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −13,997 | 0 | D |
| 2024-01-29 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −26,003 | 110,331 | D |
Loading xslF345X05/ownership.xml…